CVS Health Corporation P/E Ratio 2007–2025
CVS Health Corporation reported 55.79 of price-to-earnings ratio for fiscal 2025. That was 385.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +436.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 55.79 | +385.4% |
| FY 2024 | 11.49 | +4.7% |
| FY 2023 | 10.98 | -55.9% |
| FY 2022 | 24.91 | +70.6% |
| FY 2021 | 14.60 | +40.5% |
| FY 2020 | 10.40 | -11.7% |
| FY 2019 | 11.78 | — |
| FY 2018 | — | — |
| FY 2017 | 8.52 | -28.3% |
| FY 2016 | 11.89 | -22.4% |
| FY 2015 | 15.31 | -12.0% |
| FY 2014 | 17.39 | +29.0% |
| FY 2013 | 13.49 | +21.4% |
| FY 2012 | 11.11 | +2.4% |
| FY 2011 | 10.85 | +15.2% |
| FY 2010 | 9.42 | +11.7% |
| FY 2009 | 8.43 | -3.2% |
| FY 2008 | 8.71 | -35.9% |
| FY 2007 | 13.58 | — |
Source: CVS Health Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CVS 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
CVS Health Corporation reported 55.79 of price-to-earnings ratio for fiscal 2025. That was 385.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +436.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for CVS Health Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCVS Health Corporation — frequently asked questions
What is CVS Health Corporation's price-to-earnings ratio?
CVS Health Corporation (CVS) reported price-to-earnings ratio of 55.79 for fiscal year 2025, per its SEC filings.
How has CVS Health Corporation's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, CVS's price-to-earnings ratio grew at roughly 8.2% per year (compound annual rate), from 13.58 to 55.79.
Where does this data come from?
Figures are computed from CVS Health Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More CVS financial history
Full CVS fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →